Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12611001265965
Ethics application status
Approved
Date submitted
28/11/2011
Date registered
12/12/2011
Date last updated
14/06/2016
Type of registration
Retrospectively registered

Titles & IDs
Public title
Remote Ischaemic Preconditioning for Protection in Vascular Surgery
Scientific title
Remote Ischaemic Preconditioning for Protection in Vascular Surgery as assessed by Cardiac Troponin T and Clinical Outcomes
Secondary ID [1] 273481 0
Nil
Universal Trial Number (UTN)
Nil
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Open Abdominal Aortic Aneurysm Repair (or other Intra-Abdominal Vascular Surgery Procedure) 279269 0
Endovascular Abdominal Aortic Aneurysm Repair 279270 0
Extra-Abdominal Bypass Graft Surgery 279271 0
Condition category
Condition code
Cardiovascular 279468 279468 0 0
Diseases of the vasculature and circulation including the lymphatic system
Cardiovascular 279469 279469 0 0
Coronary heart disease

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Remote Ischaemic Preconditioning (RIPC) Intervention: Three 5-min cycles of RIPC administered by a blood pressure cuff inflated to 20 mm Hg above systolic blood pressure around the non-dominant arm, with an intervening 5 min of reperfusion between each cycle, during which time the cuff is deflated. This entire 3 x 5 min protocol is to be administered 24 hours prior to surgery, as well as after induction of anaesthesia, immediately prior to the start of the surgical procedure. Therefore, two complete RIPC protocols (6 bouts of 5 min of ischaemia) prior to surgery will be administered.
Intervention code [1] 283798 0
Prevention
Intervention code [2] 283799 0
Treatment: Other
Comparator / control treatment
Control: Sham application of the blood pressure cuff with no inflation
Control group
Placebo

Outcomes
Primary outcome [1] 286031 0
Cardiac-related clinical adverse events including (but not limited to) myocardial infarction and arrhythmias. Clinical adverse events will be assessed by standard clinical assessments performed by the primary clinician caring for the patient. If an event is suspected (e.g. MI), standard clinical investigations will be ordered as per usual practice (e.g. for MI - ECG and cardiac Troponin T blood test). All adverse events will be classified according to the Common Terminology Criteria for Adverse Events (CTCAE) and they will be recorded by the study co-ordinator.
Timepoint [1] 286031 0
Clinical adverse events: Any time peri-operatively, until discharge.
Primary outcome [2] 286032 0
Cardiac Troponin T measured in plasma using a high-sensitivity assay.
Timepoint [2] 286032 0
Blood samples: 24 hours prior to surgery, immediately pre-surgery, 6, 12, 24, 48, 72, 96 and 120 post-surgery.
Secondary outcome [1] 295021 0
Renal-related clinical adverse events including (but not limited to) renal dialysis. Assessed as per cardiac-related adverse events.
Timepoint [1] 295021 0
Clinical adverse events: Any time peri-operatively, until discharge.
Secondary outcome [2] 295184 0
Creatinine, urea and electrolytes measured in plasma.
Timepoint [2] 295184 0
Blood samples: 24 hours prior to surgery, 24 and 48 hours post-surgery.

Eligibility
Key inclusion criteria
Patients due to undergo elective or urgent major vascular surgery at Dunedin Public Hospital (open AAA repair, EVAR, extra-abdominal bypass graft surgery).
Minimum age
No limit
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
No exclusion criteria

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Sealed opaque envelopes.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Permuted block randomisation created by computer software.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
20/11/2011
Actual
25/10/2011
Date of last participant enrolment
Anticipated
Actual
20/06/2013
Date of last data collection
Anticipated
Actual
Sample size
Target
80
Accrual to date
Final
85
Recruitment outside Australia
Country [1] 3980 0
New Zealand
State/province [1] 3980 0
Otago

Funding & Sponsors
Funding source category [1] 284272 0
University
Name [1] 284272 0
University of Otago
Country [1] 284272 0
New Zealand
Primary sponsor type
Individual
Name
Andre van Rij
Address
Head of Department
Department of Surgical Sciences
Dunedin School of Medicine
University of Otago
PO Box 913
Dunedin 9054
Country
New Zealand
Secondary sponsor category [1] 283223 0
None
Name [1] 283223 0
Address [1] 283223 0
Country [1] 283223 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 286231 0
Lower South Regional Ethics Committee
Ethics committee address [1] 286231 0
Ethics committee country [1] 286231 0
New Zealand
Date submitted for ethics approval [1] 286231 0
Approval date [1] 286231 0
05/08/2011
Ethics approval number [1] 286231 0
LRS/11/07/024

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 33449 0
Prof Andre van Rij
Address 33449 0
Department of Surgical Sciences Dunedin School of Medicine University of Otago PO Box 913 Dunedin 9054
Country 33449 0
New Zealand
Phone 33449 0
+64 3474 0999 ext 58835
Fax 33449 0
Email 33449 0
andre.vanrij@otago.ac.nz
Contact person for public queries
Name 16696 0
Professor Andre van Rij
Address 16696 0
Department of Surgical Sciences
Dunedin School of Medicine
University of Otago
PO Box 913
Dunedin 9054
Country 16696 0
New Zealand
Phone 16696 0
+64 3474 0999 ext 58835
Fax 16696 0
Email 16696 0
andre.vanrij@otago.ac.nz
Contact person for scientific queries
Name 7624 0
Professor Andre van Rij
Address 7624 0
Department of Surgical Sciences
Dunedin School of Medicine
University of Otago
PO Box 913
Dunedin 9054
Country 7624 0
New Zealand
Phone 7624 0
+64 3474 0999 ext 58835
Fax 7624 0
Email 7624 0
andre.vanrij@otago.ac.nz

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
EmbaseRepeated Episodes of Remote Ischemic Preconditioning for the Prevention of Myocardial Injury in Vascular Surgery.2016https://dx.doi.org/10.1177/1538574416639150
EmbaseRemote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical procedures.2023https://dx.doi.org/10.1002/14651858.CD008472.pub3
N.B. These documents automatically identified may not have been verified by the study sponsor.